// Auto-generated - do not edit
export const substanceName = "25iP-NBOMe";
export const sources = [{"id":"protestkit","fileName":"PROTESTKIT - 25iP-NBOMe.json","displayName":"Protest Kit","size":4333},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - 25iP-NBOMe.md","displayName":"TripSit Factsheets","size":1065},{"id":"wikipedia","fileName":"WIKIPEDIA - 25iP-NBOMe.md","displayName":"Wikipedia","size":793}];
export const contents: Record<string, string> = {
  "protestkit": `{
  "url": "https://drugs.tripsit.me/25ip-nbome",
  "experiencesUrl": "https://www.reddit.com/search/?q=25iP-NBOMe",
  "name": "25iP-NBOMe",
  "aliases": [
    "25ip"
  ],
  "aliasesStr": "25ip",
  "summary": "Almost unheard-of bomamine analogue of 2C-iP. Extremely potent psychedelic with stimulating qualities. May cause potentially dangerous vasoconstriction at high doses. May induce uncomfortable body load.",
  "reagents": "Marquis: Red. | Mecke: Green. | Mandelin: Red and Green. | Froehde: Green. | Liebermann: Yellow > Brown. | Ehrlich: No colour change.",
  "classes": {
    "chemical": [
      "Substituted phenethylamines"
    ],
    "psychoactive": [
      "Psychedelic"
    ]
  },
  "toxicity": null,
  "addictionPotential": null,
  "tolerance": null,
  "crossTolerances": null,
  "roas": [
    {
      "name": "Sublingual",
      "dosage": [
        {
          "name": "Threshold",
          "value": "250ug"
        },
        {
          "name": "Light",
          "value": "300-750ug"
        },
        {
          "name": "Common",
          "value": "750-1000ug"
        },
        {
          "name": "Strong",
          "value": "1000-1500ug"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "0.5 - 1.0 hours"
        },
        {
          "name": "Duration",
          "value": "5.0 - 7.0 hours"
        },
        {
          "name": "After effects",
          "value": "1.0 - 12.0 hours"
        }
      ]
    }
  ],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Caution"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Caution"
    },
    {
      "name": "Alcohol",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Amphetamines",
      "status": "Unsafe"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Caution"
    },
    {
      "name": "Cannabis",
      "status": "Caution"
    },
    {
      "name": "Cocaine",
      "status": "Unsafe"
    },
    {
      "name": "DMT",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "DOx",
      "status": "Caution"
    },
    {
      "name": "DXM",
      "status": "Unsafe"
    },
    {
      "name": "GHB/GBL",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Gabapentinoids",
      "status": "Caution"
    },
    {
      "name": "Ketamine",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "LSD",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MAOIs",
      "status": "Caution"
    },
    {
      "name": "MDMA",
      "status": "Caution"
    },
    {
      "name": "MMC class",
      "status": "Unsafe"
    },
    {
      "name": "MXE",
      "status": "Caution"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Unsafe"
    },
    {
      "name": "Poppers",
      "status": "Caution"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Tramadol",
      "status": "Unsafe"
    }
  ],
  "effects": "Euphoria, empathy, insight, brightened colour, Closed/Open eye visuals, enhanced tactile sensation, mental/physical stimulation, decreased appetite, pupil dilation, restlessness, change in perception, ego softening, sweating/chills, muscle tension, confusion, insomnia.",
  "categorized_effects": {
    "Physical effects": [
      "decreased appetite",
      "pupil dilation",
      "sweating/chills",
      "muscle tension",
      "insomnia."
    ],
    "Mental effects": [
      "Euphoria",
      "empathy",
      "insight",
      "restlessness",
      "ego softening",
      "confusion"
    ],
    "Sensory effects": [
      "brightened colour",
      "Closed/Open eye visuals",
      "enhanced tactile sensation",
      "change in perception"
    ],
    "Uncategorized effects": [
      "mental/physical stimulation"
    ]
  }
}`,
  "tripsit-factsheets": `# 25iP-NBOMe
*Source: TripSit Factsheets (tripsit.me)*

## Summary

Almost unheard-of analogue of 2C-iP. Extremely potent psychedelic with stimulating qualities. May cause potentially dangerous vasoconstriction at high doses. May induce uncomfortable body load.

## Classification
- **Categories:** psychedelic, research-chemical, tentative
- **Also known as:** 25ip

## Dosage

### Sublingual
- **Common:** 750-1000ug
- **Light:** 300-750ug
- **Strong:** 1000-1500ug
- **Threshold:** 250ug

## Duration
- **Onset:** 30-60 minutes
- **Duration:** 5-7 hours
- **After Effects:** 1-12 hours

## Effects
- Euphoria
- empathy
- insight
- brightened colour
- Closed/Open eye visuals
- enhanced tactile sensation
- mental/physical stimulation
- decreased appetite
- pupil dilation
- restlessness
- change in perception
- ego softening
- sweating/chills
- muscle tension
- confusion
- insomnia

## Additional Information
- **Test kits:** Marquis: Red. | Mecke: Green. | Mandelin: Red and Green. | Froehde: Green. | Liebermann: Yellow > Brown. | Ehrlich: No colour change.
`,
  "wikipedia": `# 25iP-NBOMe
*Source: https://en.wikipedia.org/wiki/25iP-NBOMe*

25iP-NBOMe, also known as 2C-iP-NBOMe or NBOMe-2C-iP, is a derivative of the phenethylamine hallucinogen 2C-iP, which has been encountered as a novel designer drug.

## Toxicity and harm potential

### Neurotoxic and cardiotoxic actions

### Emergency treatment

## Interactions

## Pharmacology

The interactions of 25iP-NBOMe with the Î¼-opioid receptor have been described.

## History

25iP-NBOMe was first described in the scientific literature by at least 2014, when it was encountered as a novel designer drug.

## Society and culture

### Legal status

#### United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
`,
};
